Novartis names Harvard's Bradner head of biomedical research

September 24, 2015 4:16 PM

22 0

ZURICH, Sept 24 Novartis on Thursday named Harvard Medical School cancer specialist James Bradner as head of biomedical research with a seat on its executive committee as of March 2016.

Bradner succeeds Mark Fishman, who is retiring after a 13-year stint leading the Swiss company's drug discovery and early clinical development efforts.

Also read: Union Pacific to layoff 750 U.S. employees amid broader cost-cutting

Read more

To category page

Loading...